Stewart Abbot - Net Worth and Insider Trading

Stewart Abbot Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stewart Abbot owns 3 companies in total, including Fate Therapeutics Inc (FATE) , Adicet Bio Inc (ACET) , and Turnstone Biologics Corp (TSBX) .

Click here to see the complete history of Stewart Abbot’s form 4 insider trades.

Insider Ownership Summary of Stewart Abbot

Ticker	Comapny	Transaction Date	Type of Owner
FATE	Fate Therapeutics Inc	2015-10-06	Chief Development Officer
ACET	Adicet Bio Inc	2020-09-15	See Remarks
TSBX	Turnstone Biologics Corp	2023-07-20	Chief Scientific Officer

Stewart Abbot Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stewart Abbot Ownership Network

Ownership Network List of Stewart Abbot

No Data

Ownership Network Relation of Stewart Abbot

Stewart Abbot Owned Company Details

What does Fate Therapeutics Inc do?

Who are the key executives at Fate Therapeutics Inc?

Stewart Abbot is the Chief Development Officer of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .

Fate Therapeutics Inc (FATE) Insider Trades Summary

Over the past 18 months, Stewart Abbot made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fate Therapeutics Inc Insider Transactions

No Available Data

What does Adicet Bio Inc do?

Who are the key executives at Adicet Bio Inc?

Stewart Abbot is the See Remarks of Adicet Bio Inc. Other key executives at Adicet Bio Inc include director & 10 percent owner Orbimed Advisors Llc , director & See Remarks Chen Schor , and Chief Technology Officer Don Healey .

Adicet Bio Inc (ACET) Insider Trades Summary

Over the past 18 months, Stewart Abbot made no insider transaction in Adicet Bio Inc (ACET). Other recent insider transactions involving Adicet Bio Inc (ACET) include a net sale of 39,955 shares made by Chen Schor , a net purchase of 4,000,000 shares made by Orbimed Advisors Llc , and a net purchase of 4,000,000 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Adicet Bio Inc (ACET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 72,922 shares of Adicet Bio Inc (ACET) were sold and 8,016,000 shares were bought by its insiders, resulting in a net purchase of 7,943,078 shares.

Adicet Bio Inc (ACET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adicet Bio Inc Insider Transactions

No Available Data

What does Turnstone Biologics Corp do?

Who are the key executives at Turnstone Biologics Corp?

Stewart Abbot is the Chief Scientific Officer of Turnstone Biologics Corp. Other key executives at Turnstone Biologics Corp include director & 10 percent owner Davis Jerel , 10 percent owner Versant Ventures V, Llc , and director & 10 percent owner Orbimed Capital Gp Vi Llc .

Turnstone Biologics Corp (TSBX) Insider Trades Summary

Over the past 18 months, Stewart Abbot made no insider transaction in Turnstone Biologics Corp (TSBX). Other recent insider transactions involving Turnstone Biologics Corp (TSBX) include a net purchase of 416,666 shares made by Orbimed Advisors Llc , a net purchase of 416,666 shares made by Rishi Gupta , and a net purchase of 225,000 shares made by Davis Jerel .

In summary, during the past 3 months, insiders sold 0 shares of Turnstone Biologics Corp (TSBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turnstone Biologics Corp (TSBX) were sold and 1,283,332 shares were bought by its insiders, resulting in a net purchase of 1,283,332 shares.

Turnstone Biologics Corp (TSBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turnstone Biologics Corp Insider Transactions

No Available Data

Stewart Abbot Mailing Address

Above is the net worth, insider trading, and ownership report for Stewart Abbot. You might contact Stewart Abbot via mailing address: C/o Turnstone Biologics Corp., 9310 Athena Circle, Suite 300, La Jolla Ca 92037.

Discussions on Stewart Abbot

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.